In our ongoing commitment to support improving cost of care and operating efficiencies, we are extending the number of uses of many of the most common da Vinci X/Xi instruments beginning in the fourth quarter of 2020. By reducing price-per-use on core instruments, we expect the Extended Use Program will help our healthcare customers drive down costs associated with patient treatment.
At Intuitive, one of our priorities is long-term investment in instrument design and production to enhance the quality and durability of our offerings. Since the 2014 launch of the da Vinci Xi system, we have made continuous improvements in instrument design, informed by instrument use data from millions of procedures. These enhancements have led to improvements in instrument reliability over time. Recent testing of core da Vinci X/Xi instruments has validated their use beyond today’s 10-use limit while delivering the same da Vinci precision and dexterity customers expect from Intuitive. Additionally, as part of this program, we will be lowering the price on certain other da Vinci X/Xi instruments that are commonly used in lower acuity procedures. Together, these changes will drive instrument savings as well as create efficiencies related to less frequent inventory ordering.
We expect the Extended Use Program will result in da Vinci X/Xi instrument cost savings, depending on your specific procedure mix and utilization.
The Extended Use Program will be available to customers in the fourth quarter of 2020. Availability in other countries is dependent on country-specific regulatory requirements.
For questions regarding country-specific launch schedules or product ordering, please contact your local Intuitive sales representative for details or Intuitive Customer Service.
Da Vinci Surgical Systems
The Intuitive Surgical Endoscopic Instrument Control Systems (da Vinci X and da Vinci Xi Surgical Systems) are intended to assist in the accurate control of Intuitive Surgical Endoscopic Instruments during urologic surgical procedures, general laparoscopic surgical procedures, gynecologic laparoscopic surgical procedures, general thoracoscopic surgical procedures, thoracoscopically-assisted cardiotomy procedures, and trans-oral otolaryngology surgical procedures restricted to benign tumors and malignant tumors classified as T1 and T2, and for benign base of tongue resection procedures. The systems can also be employed with adjunctive mediastinotomy to perform coronary anastomosis during cardiac revascularization. The systems are indicated for adult and pediatric use (except for trans-oral otolaryngology surgical procedures). They are intended to be used by trained physicians in an operating room environment.
The da Vinci X and da Vinci Xi Surgical Systems are class IIb medical devices CE marked (CE 0543) under the European Medical Devices Directive (93/42/EEC), manufactured by Intuitive Surgical, Inc. Refer to Instructions For Use before use.
EndoWrist Instruments
EndoWrist Instruments, including blunt and sharp endoscopic dissectors, scissors, scalpels, forceps / pick-ups, needle holders, endoscopic retractors, electrocautery and accessories are intended for endoscopic manipulation of tissue, including grasping, cutting, blunt and sharp dissection, approximation, ligation, electrocautery, suturing, and delivery and placement of microwave and cryogenic ablation probes and accessories.
EndoWrist Instruments are class IIa and class IIb medical device CE marked (CE0543) under the European Medical Devices Directive (93/42/EEC) manufactured by Intuitive Surgical, Inc. Refer to Instructions For Use before use.